Vertex Pharmaceuticals
Company Information
As of 5/23/2022
Country
U.S.
Headquarters
Boston
Industry
Pharmaceuticals
CEO
Reshma Kewalramani
Website
Company Type
Public
Ticker
VRTX
Revenues ($M)
$7,574.4
Profits ($M)
$2,342.1
Market Value ($M)
$66,436.9
Employees
3,900
Market value as of March 31, 2022.
Company Info
Founded
-
Industry Vertical
-
U.S. Employees
-
Worldwide Employees
-
Sites
-
HQ Location
-
Web Address
<a href="http://"></a>
Date info provided (companies may opt to keep some data confidential)
-
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
-
-
Profits ($M)
-
-
Assets ($M)
-
-
Total Stockholder Equity ($M)
-
-
Profit Ratios
Profit as % of Revenues
-
Profits as % of Assets
-
Profits as % of Stockholder Equity
-
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
-
EPS % Change (from 2020)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
-
Total Return to Investors (5 year, annualized)
-
Total Return to Investors (10 year, annualized)
-
Fastest-Growing Companies
Revenue 3 Yr Growth Rank
-
Revenue 3 Yr Annual Growth Rate
-
EPS 3 Yr Growth Rank
-
EPS 3 Yr Annual Growth Rate
-
Total Return 3 Yr Rank
-
Total Return 3 Yr Annual Rate (Through June 30, 2021)
-
Beat S&P 500 3 Yr Return (18.6%)
-
Current Streak
-
Years on List
-
Sector
-
Future 50
Overall Score
-
Sector
-
Lists ranking Vertex Pharmaceuticals
Latest news for Vertex Pharmaceuticals
- Newsletters
Vertex CEO takes an earnings victory lap right before he exitsJanuary 31, 2020, 10:26 PM UTC - Newsletters
Vertex’s $950 Million Bet on Stem Cells to Cure Diabetes: Brainstorm HealthSeptember 3, 2019, 9:34 PM UTC - Health
This Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug CocktailJuly 19, 2017, 8:15 PM UTC